Novo Nordisk, Eli Lilly rake in cash from weight-loss drugs

Novo Nordisk and Eli Lilly reported booming sales from their blockbuster diabetes and weight-loss drugs as both race to keep up with consumer demand.

View original article
Contributor: Daniel Gilbert